Skip to main content
Erschienen in: European Journal of Applied Physiology 4/2007

01.11.2007 | Original Article

Prolonged administration of recombinant human erythropoietin increases submaximal performance more than maximal aerobic capacity

verfasst von: J. J. Thomsen, R. L. Rentsch, P. Robach, J. A. L. Calbet, R. Boushel, P. Rasmussen, C. Juel, C. Lundby

Erschienen in: European Journal of Applied Physiology | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

The effects of recombinant human erythropoietin (rHuEpo) treatment on aerobic power (VO2max) are well documented, but little is known about the effects of rHuEpo on submaximal exercise performance. The present study investigated the effect on performance (ergometer cycling, 20–30 min at 80% of maximal attainable workload), and for this purpose eight subjects received either 5,000 IU rHuEpo or placebo every second day for 14 days, and subsequently a single dose of 5,000 IU/placebo weekly/10 weeks. Exercise performance was evaluated before treatment and after 4 and 11 weeks of treatment. With rHuEpo treatment VO2max increased (P < 0.05) by 12.6 and 11.6% in week 4 and 11, respectively, and time-to-exhaustion (80% VO2max) was increased by 54.0 and 54.3% (P < 0.05) after 4 and 11 weeks of treatment, respectively. However, when normalizing the workload to the same relative intensity (only done at time point week 11), TTE was decreased by 26.8% as compared to pre rHuEpo administration. In conclusion, in healthy non-athlete subjects rHuEpo administration prolongs submaximal exercise performance by about 54% independently of the approximately 12% increase in VO2max.
Literatur
Zurück zum Zitat Audran M, Gareau R, Matecki S, Durand F, Chenard C, Sicart M, Marion B, Bressolle F (1999) Effects of erythropoietin administration in training athletes and possible indirect detection in doping control. Med Sci Sports Exerc 31:639–645PubMedCrossRef Audran M, Gareau R, Matecki S, Durand F, Chenard C, Sicart M, Marion B, Bressolle F (1999) Effects of erythropoietin administration in training athletes and possible indirect detection in doping control. Med Sci Sports Exerc 31:639–645PubMedCrossRef
Zurück zum Zitat Bassett DR, Howley ET (2000) Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc 32:70–84PubMedCrossRef Bassett DR, Howley ET (2000) Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc 32:70–84PubMedCrossRef
Zurück zum Zitat Berglund B, Ekblom B (1991) Effect of recombinant human erythropoietin treatment on blood pressure and some hematological parameters in healthy men. J Intern Med 229:125–130PubMedCrossRef Berglund B, Ekblom B (1991) Effect of recombinant human erythropoietin treatment on blood pressure and some hematological parameters in healthy men. J Intern Med 229:125–130PubMedCrossRef
Zurück zum Zitat Birkeland KI, Stray-Gundersen J, Hemmersbach P, Jostein H, Haug E, Bahr R (2000) Effect of rhEPO administration on serum levels of sTfR and cycling performance. Med Sci Sports Exerc 32:1238–1243PubMedCrossRef Birkeland KI, Stray-Gundersen J, Hemmersbach P, Jostein H, Haug E, Bahr R (2000) Effect of rhEPO administration on serum levels of sTfR and cycling performance. Med Sci Sports Exerc 32:1238–1243PubMedCrossRef
Zurück zum Zitat Brien AJ, Simon TL (1987) The effects of red blood cell infusion on 10-km race time. J Am Med Assoc 20:2761–2765CrossRef Brien AJ, Simon TL (1987) The effects of red blood cell infusion on 10-km race time. J Am Med Assoc 20:2761–2765CrossRef
Zurück zum Zitat Burgomaster KA, Hughes CS, Heigenhauser GJ, Bradwell SN, Gibala MJ (2005) Six sessions of sprint interval training increases muscle oxidative potential and cycle endurance capacity in humans. J Appl Physiol 98:1895–1990CrossRef Burgomaster KA, Hughes CS, Heigenhauser GJ, Bradwell SN, Gibala MJ (2005) Six sessions of sprint interval training increases muscle oxidative potential and cycle endurance capacity in humans. J Appl Physiol 98:1895–1990CrossRef
Zurück zum Zitat Calbet JAL, Lundby C, Koskolou M, Boushel R (2006) Importance of hemoglobin concentration to exercise: acute manipulations. Respir Physiol Neurobiol 151:132–140PubMedCrossRef Calbet JAL, Lundby C, Koskolou M, Boushel R (2006) Importance of hemoglobin concentration to exercise: acute manipulations. Respir Physiol Neurobiol 151:132–140PubMedCrossRef
Zurück zum Zitat di Prampero PE, Ferretti G (1990) Factors limiting maximal oxygen consumption in humans. Respir Physiol 80:113–127PubMedCrossRef di Prampero PE, Ferretti G (1990) Factors limiting maximal oxygen consumption in humans. Respir Physiol 80:113–127PubMedCrossRef
Zurück zum Zitat Jelkmann W (2005) Effects of erythropoietin on brain function. Curr Pharm Biotechnol 6:65–79PubMed Jelkmann W (2005) Effects of erythropoietin on brain function. Curr Pharm Biotechnol 6:65–79PubMed
Zurück zum Zitat Jeukendrup A, Saris WH, Brouns F, Kester AD (1996) A new validated endurance performance test. Med Sci Sports Exerc 28:266–270PubMed Jeukendrup A, Saris WH, Brouns F, Kester AD (1996) A new validated endurance performance test. Med Sci Sports Exerc 28:266–270PubMed
Zurück zum Zitat Leddy J, Limprasertkul A, Patel S, Modlich F, Buyea C, Pendergast D, Lundgren C (2007) Isocapnic hyperpnea training improves performance in competitive male runners. Eur J Appl Physiol 99:665–676PubMedCrossRef Leddy J, Limprasertkul A, Patel S, Modlich F, Buyea C, Pendergast D, Lundgren C (2007) Isocapnic hyperpnea training improves performance in competitive male runners. Eur J Appl Physiol 99:665–676PubMedCrossRef
Zurück zum Zitat Lucia A, Hoyos J, Perez M, Santalla A, Chicharro JL (2002) Inverse relationship between VO2max and economy/efficiency in world-class cyclists. Med Sci Sports Exerc 34:2079–2084PubMedCrossRef Lucia A, Hoyos J, Perez M, Santalla A, Chicharro JL (2002) Inverse relationship between VO2max and economy/efficiency in world-class cyclists. Med Sci Sports Exerc 34:2079–2084PubMedCrossRef
Zurück zum Zitat Lundby C, Thomsen JJ, Boushel R, Koskolou M, Warberg J, Calbet JAL, Robach P (2007) Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume. J Physiol 578:309–314PubMedCrossRef Lundby C, Thomsen JJ, Boushel R, Koskolou M, Warberg J, Calbet JAL, Robach P (2007) Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume. J Physiol 578:309–314PubMedCrossRef
Zurück zum Zitat McMahon FG, Vargas R, Ryan M, Jain AK, Abels RI, Perry B, Smith IL (1990) Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers. Blood 76:1718–1722PubMed McMahon FG, Vargas R, Ryan M, Jain AK, Abels RI, Perry B, Smith IL (1990) Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers. Blood 76:1718–1722PubMed
Zurück zum Zitat Miskowiak K, Inkster B, Selvaraj S, Wise R, Goodwin GM, Harmer CJ (2007) Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration. Neuropsychopharmacology Miskowiak K, Inkster B, Selvaraj S, Wise R, Goodwin GM, Harmer CJ (2007) Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration. Neuropsychopharmacology
Zurück zum Zitat Ninot G, Connes P, Caillaud C (2006) Effects of recombinant human erythropoietin injections on physical self in endurance athletes. J Sports Sci 24:383–391PubMedCrossRef Ninot G, Connes P, Caillaud C (2006) Effects of recombinant human erythropoietin injections on physical self in endurance athletes. J Sports Sci 24:383–391PubMedCrossRef
Zurück zum Zitat Parisotto R, Wu M, Ashenden MJ, Emslie KR, Gore CJ, Howe C, Kazlauskas R, Sharpe K, Trout GJ, Xie M (2001) Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis. Haematologica 86:128–137PubMed Parisotto R, Wu M, Ashenden MJ, Emslie KR, Gore CJ, Howe C, Kazlauskas R, Sharpe K, Trout GJ, Xie M (2001) Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis. Haematologica 86:128–137PubMed
Zurück zum Zitat Rice L, Ruiz W, Driscoll T, Whitley CE, Tapia R, Hachey DL, Gonzales GF, Alfrey CP (2001) Neocytolysis on descent from altitude: a newly recognized mechanism for the control of red cell mass. Ann Intern Med 134:652–656PubMed Rice L, Ruiz W, Driscoll T, Whitley CE, Tapia R, Hachey DL, Gonzales GF, Alfrey CP (2001) Neocytolysis on descent from altitude: a newly recognized mechanism for the control of red cell mass. Ann Intern Med 134:652–656PubMed
Zurück zum Zitat Russell G, Gore CJ, Ashenden MJ, Parisotto R, Hahn AG (2002) Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise. Eur J Appl Physiol 86:442–449PubMedCrossRef Russell G, Gore CJ, Ashenden MJ, Parisotto R, Hahn AG (2002) Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise. Eur J Appl Physiol 86:442–449PubMedCrossRef
Zurück zum Zitat Turner DL, Hoppeler H, Noti C, Gurtner HP, Gerber H, Schena F, Kayser B, Ferretti G (1993) Limitations to VO2max in humans after blood retransfusion. Respir Physiol 92:329–341PubMedCrossRef Turner DL, Hoppeler H, Noti C, Gurtner HP, Gerber H, Schena F, Kayser B, Ferretti G (1993) Limitations to VO2max in humans after blood retransfusion. Respir Physiol 92:329–341PubMedCrossRef
Zurück zum Zitat Wagner PD (2000) New ideas on limitations to VO2max. Med Sci Sports Exerc 28:10–14 Wagner PD (2000) New ideas on limitations to VO2max. Med Sci Sports Exerc 28:10–14
Zurück zum Zitat Warburton DER, Gledhill N, Quinney H (2000) Blood volume, aerobic power, and endurance performance: potential ergogenic effect of volume loading. Clin J Sport Med 10:59–66PubMedCrossRef Warburton DER, Gledhill N, Quinney H (2000) Blood volume, aerobic power, and endurance performance: potential ergogenic effect of volume loading. Clin J Sport Med 10:59–66PubMedCrossRef
Metadaten
Titel
Prolonged administration of recombinant human erythropoietin increases submaximal performance more than maximal aerobic capacity
verfasst von
J. J. Thomsen
R. L. Rentsch
P. Robach
J. A. L. Calbet
R. Boushel
P. Rasmussen
C. Juel
C. Lundby
Publikationsdatum
01.11.2007
Verlag
Springer-Verlag
Erschienen in
European Journal of Applied Physiology / Ausgabe 4/2007
Print ISSN: 1439-6319
Elektronische ISSN: 1439-6327
DOI
https://doi.org/10.1007/s00421-007-0522-8

Weitere Artikel der Ausgabe 4/2007

European Journal of Applied Physiology 4/2007 Zur Ausgabe

Neu im Fachgebiet Arbeitsmedizin

Das Geschlechterparadoxon in der gesundheitlich beeinträchtigten Lebenszeit – Ende eines Mythos?

Beginnend mit den 1920er-Jahren hat sich eine Vorstellung über die Geschlechterdifferenzen in Gesundheit und Mortalität etabliert, die von Lorber und Moore in dem einprägsamen Satz: „Women get sicker, but men die quicker“, zusammengefasst wurde [ 1 …, S. 13]. Tatsächlich erscheinen vor dem Hintergrund der höheren Lebenserwartung der Frauen die Studienergebnisse zu den Geschlechterdifferenzen in der Morbidität überraschend, wonach Frauen im Durchschnitt einen schlechteren Gesundheitszustand aufweisen als Männer [

Gesunde Lebenserwartung: Ein kritischer Blick auf Nutzen und Potenziale des demographischen Gesundheitsindikators

Open Access Leitthema

Die demographische Alterung hat vielfältige gesellschaftliche Konsequenzen, deren Ausmaß wesentlich vom Gesundheitszustand der Bevölkerung abhängt. Um diesen analysieren und bewerten zu können, wurden spezielle Kennziffern entwickelt, die in …

Wie hat sich die Lebenserwartung ohne funktionelle Einschränkungen in Deutschland entwickelt? Eine Analyse mit Daten des Deutschen Alterssurveys (DEAS)

Deutschland erfährt, wie andere Hocheinkommensstaaten, aufgrund kontinuierlich rückläufiger Mortalität und niedriger Geburtenraten tiefgreifende demografische Veränderungen. Der demografische Wandel führt in Deutschland zu einem zunehmend höheren …

Hitzeschutz im Fokus der hessischen Betreuungs- und Pflegeaufsicht

Open Access Klimawandel Übersichtsartikel

Im Sommer 2023 kündigte das Bundesministerium für Gesundheit (BMG) einen nationalen Hitzeschutzplan an und forderte die Länder auf, zu prüfen, „ob die Warnstufen des [Deutschen Wetterdienstes] DWD mit der Durchführung von Akutmaßnahmen …